Skip to content

Press Releases

年 : 2021

日付 タイトル
2021/09/27 Randomized trial demonstrates whole-genome sequencing leads to precision care for critically ill infants
2021/09/15 Illumina Accelerator Invests in Seven Genomics Startups for Third Global Cycle
2021/09/09 Illumina Commits to Net Zero Global Greenhouse Gas Emissions by 2050
2021/09/07 Illumina Partners with Merck to Develop and Commercialize Companion Diagnostic and Research Tests for Use in Identifying Specific Cancer Mutations
2021/08/30 Illumina To Webcast Upcoming Investor Conference
2021/08/18 Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test
2021/07/28 Illumina to Webcast Upcoming Investor Conference
2021/07/22 Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase
2021/07/13 Illumina to Announce Second Quarter 2021 Financial Results on Thursday, August 5, 2021
2021/06/21 栄研化学とイルミナ社、日本における遺伝子検査システムの開発および商業化に関する契約締結を発表
2021/06/01 Illumina Supports Nationwide Program across Belgium to Assess Whole Genome Sequencing for Developmental Disorders Diagnosis
2021/05/31 Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand
2021/05/27 Illumina To Webcast Upcoming Investor Conference
2021/05/17 Illumina Appoints Susan Tousi as Chief Commercial Officer and Dr. Alex Aravanis as Chief Technology Officer, Head of Research and Product Development
2021/04/29 Illumina To Webcast Upcoming Investor Conference
2021/04/29 Illumina Files Action for Annulment of European Commission’s Decision Asserting Jurisdiction to Review GRAIL Acquisition
2021/04/28 Illumina to Donate US $60 Million in Sequencing Capabilities to Establish a Global Pathogen Genomics Initiative
2021/04/27 Illumina Reports Financial Results for First Quarter of Fiscal Year 2021
2021/04/22 Illumina and Kartos Therapeutics Announce New Oncology Partnership to Develop an NGS-Based TP53 Companion Diagnostic
2021/04/20 Illumina Remains Committed to GRAIL Acquisition to Accelerate Access to Breakthrough Multi-Cancer Early Detection Blood Test
2021/04/05 Illumina Announces Preliminary Revenue for First Quarter Fiscal Year 2021
2021/03/18 Illumina Announces Board Changes
2021/03/11 Illumina and Harvard Pilgrim Health Care Real-World Evidence Study Demonstrates Cost-Effectiveness of Offering NIPT to All Pregnant Women
2021/03/05 Illumina and R-Pharm Secure Registration for Two Complete IVD Sequencing Platforms in Russia
2021/02/08 Illumina Accelerator Invests in Nine Genomics Startups for Second Global Cycle
2021/02/04 Illumina Supports National Program to Evaluate Potential of Comprehensive Genomic Profiling in Late Stage Cancer Real-World Setting Across Belgium
2021/02/03 造血器腫瘍遺伝子パネル検査に関する開発および商業化契約締結について
2021/01/31 Illumina and Sequoia Capital China Partner to Launch Genomics Incubator in China
2021/01/25 Illumina to Announce Fourth Quarter & Full Year 2020 Financial Results on Thursday, February 11, 2021
2021/01/20 Illumina Wins Patent Infringement Suit against BGI in the UK
2021/01/11 新しいバイオインフォマティクスソリューションにより、より大規模なマルチオミクス研究が可能に
2021/01/11 イルミナが包括的なゲノムプロファイリングを前進させるためBristol Myers Squibb、Kura Oncology、Myriad GeneticsおよびMerckとの新しいさまざまな腫瘍学パートナーシップを発表
2021/01/05 Illumina and Helix Collaborate to Assess Prevalence of New SARS-CoV-2 UK Variant (B.1.1.7) in the US and Develop National Surveillance Infrastructure